Categories: Manufacturers (D)

Bio-Med Private Limited, C-96, Bulandshahr Road Industrial Area, Ghaziabad-201009, U.P.India

 

Company Name : Bio-Med Private Limited

Address : C-96, Bulandshahr Road Industrial Area, Ghaziabad-201009, U.P.India

Tel No: 91-120- 2700881, 2753255, 4157534

Email : saryugarg@yahoo.com

Website : http://www.biomed.co.in/

Company Profile

Bio-Med (P) Limited was established with an abiding faith in the wisdom enshrined in the age-old saying………….

“Prevention is better than cure”

Bio-Med embarked on its noble mission of producing world-class vaccines essential to the needs of a developing country. India, with its tropical climate is quite prone to a number of diseases that sometimes assumed epidemic proportions in the past.

Initially, most vaccines had to be imported at the cost of nation’s self pride with a considerable foreign exchange outflow. With this background in view, the foundation stone of Bio-Med was laid on May 11, 1972. A dedicated and committed team of scientists started with research & development on animal vaccines in 1973.

The company was registered & incorporated for the manufacture of vaccines to protect animals & humans against infectious diseases. BIOMED got the Drug Manufacturing license from the State Government for manufacture of Poultry Vaccines in December 1974 and became the first poultry vaccine manufacturing unit of the private sector in the country.

Over the years equipped with state of the art modern facilities, technology & dedicated technical staff, Bio-Med has established its name all over India, in variety of Animal Vaccines for Poultry, Cattle & Sheep within 5 years of its establishment.

Bio-Med entered into field of Human Vaccines by starting manufacture of Oral Polio Vaccine in January 1995, which now has added four more vaccines and few more are in the pipe line. The vaccines are manufactured and tested as per the highest standards possible, in full compliance with WHO TRS, Drug’s & Cosmetic Act, Indian Pharmacopoeias .

Bio-Med had launched India’s first indigenously manufactured drug Botulinum toxin Type A under the brand name BOTOGenie™ in Jan 2007. This product has far reaching uses in cosmetology, neurology, urology, orthopedics and ophthalmology etc.

In 2008, we had the biggest feat of developing the World’s first Vi Conjugated Typhoid Vaccine- Peda TyphTM. This vaccine can protect babies as young as three months old who could not be protected with the hitherto available vaccines along with children and adults for much longer duration. By providing important service to the health programme of nation and its people at large, for more than 3 decades, Bio-Med vaccines have not only earned the choice of prescription of the medical and veterinary fraternity throughout Indian sub-continent, but have started creating significant mark in the International market as well.

The Pharma Times News Bureau

Recent Posts

World Diabetes Day Survey: Diabetologists and Endocrinologists demand for AI-Based Training and Upskilling in Diabetes Care

 A striking 90% of the 3000 Diabetologists and Endocrinologists surveyed, emphasised the importance of continuous…

3 days ago

Doctors warn diabetes patients about risk of smoking

People who smoke are also at much higher risk of developing diabetes compared to non-smokers…

4 days ago

CPHI & PMEC India Expo: Encouraging affordable solutions in India’s march towards a $130 Billion Pharma Market by 2030

17th edition of CPHI& PMEC India Expo to be held from 26th November-28thNovember 2024, at the India…

4 days ago

Sringeri Sharada Equitas Hospital Revolutionizing Cancer Care with the Launch of Low-cost, High Quality Radiation Therapy

The launch signifies Equitas’ redefined commitment to bring world-class cancer radiation therapy accessible to all.…

5 days ago